Johannes Oldenburg
Johannes Oldenburg
Professor for Transfusion Medicine, University Bonn
Email verificata su ukb.uni-Bonn.de
Titolo
Citata da
Citata da
Anno
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
S Rost, A Fregin, V Ivaskevicius, E Conzelmann, K Hörtnagel, HJ Pelz, ...
Nature 427 (6974), 537-541, 2004
13522004
Emicizumab prophylaxis in hemophilia A with inhibitors
J Oldenburg, JN Mahlangu, B Kim, C Schmitt, MU Callaghan, G Young, ...
New England Journal of Medicine 377 (9), 809-818, 2017
6022017
Haemophilia A: mutation type determines risk of inhibitor formation
R Schwaab, HH Brackmann, C Meyer, J Seehafer, M Kirchgesser, ...
Thrombosis and haemostasis 74 (12), 1402-1406, 1995
4081995
The genetic basis of resistance to anticoagulants in rodents
HJ Pelz, S Rost, M Hünerberg, A Fregin, AC Heiberg, K Baert, ...
Genetics 170 (4), 1839-1847, 2005
3672005
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
SC Gouw, HM van den Berg, J Oldenburg, J Astermark, PG de Groot, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2922-2934, 2012
3452012
Emicizumab prophylaxis in patients who have hemophilia A without inhibitors
J Mahlangu, J Oldenburg, I Paz-Priel, C Negrier, M Niggli, ME Mancuso, ...
New England Journal of Medicine 379 (9), 811-822, 2018
3372018
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation
C Geisen, M Watzka, K Sittinger, M Steffens, L Daugela, E Seifried, ...
Thrombosis and haemostasis 94 (10), 773-779, 2005
3352005
Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A
J Astermark, J Oldenburg, A Pavlova, E Berntorp, AK Lefvert, ...
Blood 107 (8), 3167-3172, 2006
3162006
Immune Tolerance for the Treatment of Factor VIII Inhibitors‐Twenty Years'‘Bonn Protocol’
HH Brackmann, J Oldenburg, R Schwaab
Vox sanguinis 70, 30-35, 1996
3031996
Genetic risk factors for inhibitors to factors VIII and IX
J Oldenburg, A Pavlova
Haemophilia 12, 15-22, 2006
3022006
Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males
O El-Maarri, T Becker, J Junen, SS Manzoor, A Diaz-Lacava, R Schwaab, ...
Human genetics 122 (5), 505-514, 2007
2872007
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
SC Gouw, HM van den Berg, K Fischer, G Auerswald, M Carcao, ...
Blood, The Journal of the American Society of Hematology 121 (20), 4046-4055, 2013
2722013
The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development
J Astermark, E Berntorp, GC White, BL Kroner, MIBS Study Group
Haemophilia 7 (3), 267-272, 2001
2682001
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
J Astermark, J Oldenburg, J Carlson, A Pavlova, K Kavakli, E Berntorp, ...
Blood 108 (12), 3739-3745, 2006
2642006
Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic …
H Pfeifer, B Wassmann, A Pavlova, L Wunderle, J Oldenburg, ...
Blood, The Journal of the American Society of Hematology 110 (2), 727-734, 2007
2562007
Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens
J Oldenburg
Blood, The Journal of the American Society of Hematology 125 (13), 2038-2044, 2015
2422015
HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII
J Oldenburg, JK Picard, R Schwaab, HH Brackmann, EGD Tuddenham, ...
Thrombosis and haemostasis 77 (02), 238-242, 1997
2361997
Haemophilia A: from mutation analysis to new therapies
J Graw, HH Brackmann, J Oldenburg, R Schneppenheim, M Spannagl, ...
Nature Reviews Genetics 6 (6), 488-501, 2005
2302005
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.
JK Rockstroh, U Spengler, T Sudhop, S Ewig, A Theisen, U Hammerstein, ...
American Journal of Gastroenterology (Springer Nature) 91 (12), 1996
1991996
Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population
SC Lee, SS Ng, J Oldenburg, PY Chong, S Rost, JY Guo, HL Yap, ...
Clinical Pharmacology & Therapeutics 79 (3), 197-205, 2006
1962006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20